Alerts will be sent to your verified email
Verify EmailTRIMURTHI
|
Novelix Pharma
|
Positron Energy
|
Sunrise Efficient
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
0.0 | 28.49 % | 27.13 % |
|
5yr average Equity Multiplier
|
1.26 | 2.58 | 4.36 |
|
5yr Average Asset Turnover Ratio
|
0.84 | 2.01 | 1.89 |
|
5yr Avg Net Profit Margin
|
-14.11 % | 5.86 % | 6.21 % |
|
Price to Book
|
15.84 | 0.0 | 0.0 |
|
P/E
|
62.5 | 6.41 | 12.68 |
|
5yr Avg Cash Conversion Cycle
|
29.1 Days | 12.01 Days | 125.98 Days |
|
Inventory Days
|
34.04 Days | 14.67 Days | 47.35 Days |
|
Days Receivable
|
55.38 Days | 25.28 Days | 94.07 Days |
|
Days Payable
|
55.7 Days | 26.53 Days | 48.56 Days |
|
5yr Average Interest Coverage Ratio
|
-17.77 | 12.35 | 10.51 |
|
5yr Avg ROCE
|
-15.4 % | 25.69 % | 39.14 % |
|
5yr Avg Operating Profit Margin
|
-16.49 % | 7.82 % | 9.22 % |
|
5 yr average Debt to Equity
|
0.05 | 0.7 | 1.56 |
|
5yr CAGR Net Profit
|
35.78 % | 138.58 % | 115.15 % |
|
5yr Average Return on Assets
|
-13.36 % | 11.43 % | 12.27 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.43 % | 72.2 % | 41.46 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-17.49 % | 0.2 % | -58.54 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Novelix Pharma
|
Positron Energy
|
Sunrise Efficient
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|